According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...
After a midnight joyride, I was not allowed near the driver’s seat for a year. But little did Dad know, I had a secret ...
Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Watch Canada, China relations on the mend with potential summit between Carney and Xi in the cards Video Online, on GlobalNews.ca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback